Concentrix (CNXC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Revenue grew 47.4% year-over-year to $2.38 billion, driven by the Webhelp acquisition and strong demand, exceeding expectations.
Non-GAAP operating income rose 46% to $321 million; Adjusted EBITDA up 47% to $380 million.
Net income declined to $66.8 million, reflecting higher SG&A, integration, and amortization costs.
Generated over $200 million in adjusted free cash flow and returned $60 million to shareholders via dividends and buybacks.
Integration of Webhelp is ahead of schedule, expanding global reach and supporting above-market revenue growth.
Financial highlights
Q2 revenue reached $2.38 billion, up from $1.61 billion year-over-year; pro forma constant currency growth was 4%.
Non-GAAP net income was $183 million, up $46 million year-over-year; non-GAAP EPS was $2.69, up $0.06.
GAAP net income was $66.8 million, impacted by $116 million in amortization and $31 million in Webhelp integration costs.
Adjusted EBITDA for the quarter was $379.6 million (15.9% margin), up from $258.8 million year-over-year.
Adjusted free cash flow for Q2 was $202 million; cash and equivalents at quarter end were $207 million.
Outlook and guidance
Raised full-year 2024 revenue guidance to $9.58–$9.675 billion, reflecting 2.5%–3.5% pro forma constant currency growth.
Q3 revenue expected at $2.35–$2.4 billion, with non-GAAP operating income of $330–$350 million and EPS of $2.76–$3.04.
Full-year non-GAAP EPS expected at $11.40–$12.07; adjusted free cash flow outlook confirmed at $700 million.
Dividend of $0.3025 per share declared for Q3 2024, with intent to continue quarterly dividends.
Net leverage targeted to fall to 2.6x Adjusted EBITDA by year-end.
Latest events from Concentrix
- AI-driven IX suite accelerates margin growth and cash flow, supporting debt reduction and future value.CNXC
Canaccord Genuity's 46th Annual Growth Conference - Q2 revenue up 1.9% with record cash flow, but margins fell amid restructuring costs.CNXC
Q2 2026 - All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 2026 - Revenue up 5.4% to $2.5B, but margins and net income declined despite strong AI-driven growth.CNXC
Q1 2026 - Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing - Record revenue and cash flow in 2025, with 2026 growth expected despite a goodwill impairment.CNXC
Q4 2025 - FY25 guidance projects modest revenue growth, margin expansion, and higher free cash flow.CNXC
Q4 2024